Normal immunoglobulin human 4g/20ml solution for infusion vials
NHS hospitals in England used £22,235,388 of indicative cost of Normal immunoglobulin human 4g/20ml solution for infusion vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 40.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Normal immunoglobulin human 4g/20ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Normal immunoglobulin human 4g/20ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Cambridge Univ Hosp Nhs Foundation Trust | £4,707,456 |
| Oxford University Hospitals Nhs Ft | £2,054,820 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,345,500 |
| University Hospitals Plymouth Nhs Trust | £1,337,220 |
| Salford Royal Nhs Foundation Trust | £1,333,908 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,224,612 |
| Barts Health Nhs Trust | £980,904 |
| Leeds Teaching Hpls Nhs Trust | £917,976 |
| Nottingham University Hospitals Trust | £905,556 |
| University Hospital Southampton Nhs Ft | £823,584 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.